ProQR Therapeutics N.V. (NASDAQ: PRQR) Stock Information | RedChip

ProQR Therapeutics N.V. (NASDAQ: PRQR) Listen to this Section


$2.21
-0.0200 ( -0.90% ) 181.0K

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Market Data


Open


$2.21

Previous close


$2.23

Volume


181.0K

Market cap


$179.70M

Day range


$2.08 - $2.27

52 week range


$1.11 - $3.29

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 70 Aug 08, 2024
6-k Quarterly Reports 1 May 22, 2024
6-k Quarterly Reports 72 May 09, 2024
6-k Quarterly Reports 2 May 08, 2024
6-k Quarterly Reports 9 Apr 23, 2024
6-k Quarterly Reports 2 Apr 19, 2024
6-k Quarterly Reports 2 Mar 13, 2024
20-f Annual reports 122 Mar 13, 2024
6-k Quarterly Reports 2 Feb 15, 2024
6-k Quarterly Reports 2 Jan 19, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.